Sri Lanka · Delayed Price · Currency is LKR Hemas Holdings Statistics
Total Valuation
Hemas Holdings has a market cap or net worth of LKR 93.47 billion. The enterprise value is 84.22 billion.
| Market Cap | 93.47B |
| Enterprise Value | 84.22B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Jun 30, 2026 |
Share Statistics
Hemas Holdings has 3.00 billion shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 3.00B |
| Shares Outstanding | 3.00B |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 7.25% |
| Owned by Institutions (%) | 7.73% |
| Float | 680.01M |
Valuation Ratios
The trailing PE ratio is 10.51 and the forward PE ratio is 9.75.
| PE Ratio | 10.51 |
| Forward PE | 9.75 |
| PS Ratio | 0.73 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | 9.95 |
| P/OCF Ratio | 7.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.33, with an EV/FCF ratio of 8.96.
| EV / Earnings | 9.44 |
| EV / Sales | 0.66 |
| EV / EBITDA | 5.33 |
| EV / EBIT | 6.21 |
| EV / FCF | 8.96 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.72 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.83 |
| Interest Coverage | 13.08 |
Financial Efficiency
Return on equity (ROE) is 17.20% and return on invested capital (ROIC) is 17.64%.
| Return on Equity (ROE) | 17.20% |
| Return on Assets (ROA) | 8.12% |
| Return on Invested Capital (ROIC) | 17.64% |
| Return on Capital Employed (ROCE) | 19.61% |
| Weighted Average Cost of Capital (WACC) | 6.28% |
| Revenue Per Employee | 24.63M |
| Profits Per Employee | 1.72M |
| Employee Count | 5,173 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 3.89 |
Taxes
In the past 12 months, Hemas Holdings has paid 4.43 billion in taxes.
| Income Tax | 4.43B |
| Effective Tax Rate | 32.29% |
Stock Price Statistics
The stock price has increased by +7.96% in the last 52 weeks. The beta is 0.33, so Hemas Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +7.96% |
| 50-Day Moving Average | 31.76 |
| 200-Day Moving Average | 32.97 |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemas Holdings had revenue of LKR 127.36 billion and earned 8.92 billion in profits. Earnings per share was 2.97.
| Revenue | 127.36B |
| Gross Profit | 41.43B |
| Operating Income | 13.24B |
| Pretax Income | 13.72B |
| Net Income | 8.92B |
| EBITDA | 15.06B |
| EBIT | 13.24B |
| Earnings Per Share (EPS) | 2.97 |
Balance Sheet
The company has 17.78 billion in cash and 7.81 billion in debt, with a net cash position of 9.97 billion or 3.33 per share.
| Cash & Cash Equivalents | 17.78B |
| Total Debt | 7.81B |
| Net Cash | 9.97B |
| Net Cash Per Share | 3.33 |
| Equity (Book Value) | 57.73B |
| Book Value Per Share | 19.03 |
| Working Capital | 28.34B |
Cash Flow
In the last 12 months, operating cash flow was 11.81 billion and capital expenditures -2.41 billion, giving a free cash flow of 9.40 billion.
| Operating Cash Flow | 11.81B |
| Capital Expenditures | -2.41B |
| Depreciation & Amortization | 1.83B |
| Net Borrowing | -2.15B |
| Free Cash Flow | 9.40B |
| FCF Per Share | 3.14 |
Margins
Gross margin is 32.53%, with operating and profit margins of 10.39% and 7.00%.
| Gross Margin | 32.53% |
| Operating Margin | 10.39% |
| Pretax Margin | 10.77% |
| Profit Margin | 7.00% |
| EBITDA Margin | 11.83% |
| EBIT Margin | 10.39% |
| FCF Margin | 7.38% |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.04%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 3.04% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 33.67% |
| Buyback Yield | -0.50% |
| Shareholder Yield | 2.55% |
| Earnings Yield | 9.54% |
| FCF Yield | 10.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Hemas Holdings is 43.60, which is 39.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 43.60 |
| Price Target Difference | 39.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on April 29, 2025. It was a forward split with a ratio of 5.
| Last Split Date | Apr 29, 2025 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Hemas Holdings has an Altman Z-Score of 3.58 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.58 |
| Piotroski F-Score | 8 |